---
schema_version: "secwatch.filing_event.v1"
accession: "0001520138-24-000404"
form_type: "8-K"
ticker: "BIVI"
cik: "0001580149"
company_name: "BIOVIE INC."
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T09:14:23.966834+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioVie closes registered direct offering raising $3.24M gross proceeds at $2.83/share

## Summary
- Closed registered direct offering of 1,146,000 shares at $2.83/share, gross proceeds ~$3.24M.
- Net proceeds after fees of ~$419K are approx. $2.82M; funds for working capital and corporate purposes.
- ThinkEquity acted as sole placement agent; offering made under shelf registration S-3.
- BioVie is a clinical-stage company developing therapies for liver disease and neurological disorders.

## SEC filing metadata
- accession: 0001520138-24-000404
- form_type: 8-K
- ticker: BIVI
- cik: 0001580149
- company_name: BIOVIE INC.
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1580149/000152013824000404/0001520138-24-000404-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1580149/000152013824000404/bivi-20241029_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001520138-24-000404
- JSON: https://secwatch.observer/filing/0001520138-24-000404.json
- Plain text: https://secwatch.observer/filing/0001520138-24-000404.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.